Editing Genes, Framing Laws: Is India Ready for CRISPR Patents?

From disease-resistant crops to possible cures for genetic disorders, CRISPR is breaking through in India. Laksh A. Varma asks whether our patent law, careful as it is about life forms, can keep up.

Cite this piece

When Indian farmers sow new seeds a decade from now on, there is a good possibility that CRISPR (the gene editing tool once described as a “word processor for DNA”) will be behind them. From disease resistant crops to possible cures for genetic disorders, CRISPR is breakthrough in India, can our laws keep up?

How CRISPR rewrites DNA

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) works like precise genetic scissors guided by GPS. Scientists design a short piece of RNA (the “guide RNA”) that matches a target DNA sequence inside a cell. The Cas9 protein, attached to this guide, cuts the DNA at exactly that spot. Once cut, the cell’s natural repair machinery takes over but researchers can steer this repair to disable a gene, correct it, or insert new genetic material.

This method is faster, cheaper and more accurate than older gene editing tools like zinc finger nucleases or TALENs. It has opened the door to tackling diseases like sickle cell anemia and certain cancers, and is already being used in agriculture to develop stronger crops.

For instance, scientists have edited rice to resist bacterial blight, a major threat to yields CRISPR has produced mushroom that brown more slowly, helping reduce food waste. In China researchers have created wheat resistant to powdery mildew (fungal disease) and in India, the Indian Council of Agriculture Research (ICAR) is backing projects using CRISPR on rice and mustard to boost disease resistance and productivity. Unlike many traditional GMOs, CRISPR can edit an organism’s own DNA without inserting foreign genes, which makes it more acceptable to regulators and the public in some countries.

Where India draws its patent line

India’s Patent Act, 1970, is careful about patents that touch life forms and biological processes. Section 3(j) excludes “plants and animals in whole or any part thereof other than microorganism, but including seeds, varieties and species and essentially biological processes for production or propagation of plants and animals.”

So, where does CRISPR sit? It’s not just a plant or an animal it’s a method to edit genes. If the inventions relates to a microorganism or a man made, non-essentially biological process, it might clear the bar. But if it leads to a new plant variety or animal breed, patent protection of plant varieties and Farmer’s Right Act (PPVFR), which grants different rights than a patent.

The global CRISPR patent war and India’s quiet front

Globally, CRISPR has sparked one of the fiercest patents battles in biotech history. The University of California, Berkeley team led by Doudna and Charpentier first filed patent for using CRISPR in bacterial cells. Meanwhile, the Broad Institute (Harvard & MIT) filed overlapping patents for using CRISPR in plant and animal cells and secured faster examination at the US Patent Office.

After years of legal fights, Including the interference proceedings at the US Patent and Trademark Office (USPTO), The USPTO upheld key Broad patents while UC continues to hold patents in Europe and elsewhere. This has created a tangled web of overlapping claims, with biotech companies like CRISPR therapeutics and Editas Medicine paying millions in licensing fees or risking lawsuits if they go it alone.

In India, there haven’t been headlines CRISPR court fights yet, but multiple CRISPR related patent filing exist. These cover variation of Cas proteins, guides RNAs, delivery methods and gene editing kits. Many remain under examination or get narrowed significantly, especially when they intersects with India’s strict exclusions on plant varieties and essential biological processes.

The policy puzzle India must solve

CRISPR’s promise brings tough questions. Should India allow patents on powerful gene editing tools and the crops they produce? Or does that risk putting too much control over seeds and food production in private hands?

Supporters say patents are vital to attract investments biotech research is expensive and companies need exclusivity to recover costs. Critics worry patents could limit access for local researchers and farmers, and might lead to private control over traits critical for food security. Beyond access. There are biosafety and ethical concerns how far should we push gene editing when ecological risks aren’t fully understood?

Balancing innovation and public interest

India does have tools like compulsory licensing to prevent abusive monopolies, but whether these would work well for fast moving gene editing technologies is unclear. Clearer guidance from the Indian patent office could help innovators understand what’s patentable and what’s off limits so India’s IP regime can balance incentives with the public good.

Where do we go from here?

As India pushes to become a biotech hub, it can’t dodge the gene editing question for long. Should we stick to strict exclusions, or update them to reflect modern sciences? A balanced, clear approach could give Indian researchers and startups confidence to invest in breakthrough biotech without ignoring farmer’s rights, biosafety or fair access to new technologies.

CRISPR won’t wait and if India wants seat at the table in the gene editing era, its patent law can’t afford to lag behind.

How to cite this piece

OSCOLA

Laksh A. Varma, ‘Editing Genes, Framing Laws: Is India Ready for CRISPR Patents?’ (Vox Populi, 11 October 2026) <https://vox-populi-nine.vercel.app/articles/editing-genes-framing-laws-is-india-ready-for-crispr-patents> accessed 17 November 2026.

Bluebook

Laksh A. Varma, Editing Genes, Framing Laws: Is India Ready for CRISPR Patents?, Vox Populi (Oct. 11, 2026), https://vox-populi-nine.vercel.app/articles/editing-genes-framing-laws-is-india-ready-for-crispr-patents.

Tech & Privacy Article

Artificial Intelligence and Copyright Law: A Legal Grey Area

When Machines Create: Who Owns the Copyright? Artificial intelligence is transforming creativity, but who owns what machines produce? This article explores the legal grey areas surrounding AI-generated content, copyright ownership, training data and infringement under Indian law. It examines emerging judicial developments and proposes legislative reforms to balance technological innovations.

Suvidhi Jain 17 min read
Human Rights Essay

To Be a Girl

“I thought growing up would fix everything.” Priya Shah on being watched, being told she is too much, and why a girl’s anger in India is not weakness but memory.

Priya Shah 5 min read

One email, when there is something worth reading.

New pieces and explainers from Vox Populi, straight to your inbox.

No spam. Unsubscribe any time by replying to any email.